Viewing nowBonogro Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

MFDS item code 201004244 · Notified 2010.06.30 · Insurance code 655604220
Treatment and prevention of postmenopausal osteoporosis
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis is a disease characterized by weakened bones and an increased risk of fractures, which is particularly common among postmenopausal women. Taking this medication helps maintain bone strength and reduce the risk of fractures. It is available in tablet form in two dosages: 75 mg and 150 mg, allowing appropriate use according to the patient's condition. Regular use can effectively prevent the progression of osteoporosis and maintain healthy bones.
As Risedronate Sodium, the dose is 150 mg taken orally once a month. Since food can interfere with the absorption of this medication, take it at least 30 minutes before consuming food or drinks other than water for optimal absorption. This medication should be taken with a sufficient amount of plain water (170 to 230 mL) in an upright position, and should not be chewed or sucked. Patients should avoid lying down for at least 30 minutes after taking.
This medication can irritate the stomach and esophagus, so patients with upper gastrointestinal diseases such as gastritis, esophagitis, or esophageal ulcers should take it with caution. It must be taken with a sufficient amount of water, and patients should avoid lying down for at least 30 minutes after taking the medicine. If there are issues with the esophagus or symptoms of dysphagia occur, the medication should be stopped immediately, and a doctor should be consulted. Patients with esophageal motility disorders, hypersensitivity to this drug, hypocalcemia, pregnant or potentially pregnant women, breastfeeding women, and those with severe renal impairment should not take this medication. This medication contains lactose, so patients with lactose intolerance should avoid it. As a bisphosphonate, serious side effects such as osteonecrosis of the jaw, atypical femoral fractures, and severe gastrointestinal bleeding can rarely occur; any unusual symptoms should be reported to healthcare professionals immediately. Taking this medication with food or medications containing divalent cations such as calcium, magnesium, iron, or aluminum can interfere with its absorption, so a sufficient interval should be maintained. Pregnant or breastfeeding women should avoid taking this medicine or consult a specialist, and safety in children under 18 has not been established. In case of overdose, symptoms of hypocalcemia may appear, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to another container.
Severe allergic reactions (hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness), severe skin reactions (severe rashes with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes), respiratory problems (shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever), liver abnormalities (jaundice) (yellowing of skin or eyes (jaundice), extreme lethargy)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain the drug's effectiveness for a longer period.
Bright blue rectangular film-coated tablet
1 tablet/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.